Notably, ATRX-deficiency causes exhibit dysregulation of cell cycle phase transitions is mediated by checkpoint kinase 1 [29], which may be a potential a target for overcoming radioresistance in GBM harboring the wild-type ATRX gene. This evidence concerns the gene CHEK1 and glioblastoma.